Regulus Therapeutics
Christopher Aker has extensive experience in the legal field, having held various positions such as Senior Vice President & General Counsel at Regulus Therapeutics. Christopher also served as Corporate Counsel at companies like Cureline and SUGEN, Inc. Christopher has a JD from Santa Clara University School of Law and a BA in International Relations from the University of California, Davis. Christopher has a proven track record of success in managing legal affairs and intellectual property strategy.
Regulus Therapeutics
1 followers
Regulus Therapeutics Inc. (Nasdaq:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.